Global Sevoflurane (Sevoflurane Source) Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Sevoflurane (Sevoflurane Source) market size is predicted to grow from US$ 1169 million in 2025 to US$ 1458 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
LP Information, Inc. (LPI) ' newest research report, the “Sevoflurane (Sevoflurane Source) Industry Forecast” looks at past sales and reviews total world Sevoflurane (Sevoflurane Source) sales in 2024, providing a comprehensive analysis by region and market sector of projected Sevoflurane (Sevoflurane Source) sales for 2025 through 2031. With Sevoflurane (Sevoflurane Source) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane (Sevoflurane Source) industry.
This Insight Report provides a comprehensive analysis of the global Sevoflurane (Sevoflurane Source) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane (Sevoflurane Source) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sevoflurane (Sevoflurane Source) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane (Sevoflurane Source) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane (Sevoflurane Source).
This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane (Sevoflurane Source) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Sevoflurane (Sevoflurane Source) market?
What factors are driving Sevoflurane (Sevoflurane Source) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sevoflurane (Sevoflurane Source) market opportunities vary by end market size?
How does Sevoflurane (Sevoflurane Source) break out by Type, by Application?
The global Sevoflurane (Sevoflurane Source) market size is predicted to grow from US$ 1169 million in 2025 to US$ 1458 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
LP Information, Inc. (LPI) ' newest research report, the “Sevoflurane (Sevoflurane Source) Industry Forecast” looks at past sales and reviews total world Sevoflurane (Sevoflurane Source) sales in 2024, providing a comprehensive analysis by region and market sector of projected Sevoflurane (Sevoflurane Source) sales for 2025 through 2031. With Sevoflurane (Sevoflurane Source) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane (Sevoflurane Source) industry.
This Insight Report provides a comprehensive analysis of the global Sevoflurane (Sevoflurane Source) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane (Sevoflurane Source) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sevoflurane (Sevoflurane Source) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane (Sevoflurane Source) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane (Sevoflurane Source).
This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane (Sevoflurane Source) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drugs
- Generic Drugs
- Hospital
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hengrui
- Baxter
- Maruishi
- AbbVie
- Piramal
- Viatris
- PT Novell Pharmaceutical
- Lunan Pharma
What is the 10-year outlook for the global Sevoflurane (Sevoflurane Source) market?
What factors are driving Sevoflurane (Sevoflurane Source) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sevoflurane (Sevoflurane Source) market opportunities vary by end market size?
How does Sevoflurane (Sevoflurane Source) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sevoflurane (Sevoflurane Source) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sevoflurane (Sevoflurane Source) by Country/Region, 2020, 2024 & 2031
2.2 Sevoflurane (Sevoflurane Source) Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Sevoflurane (Sevoflurane Source) Sales by Type
2.3.1 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
2.3.2 Global Sevoflurane (Sevoflurane Source) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Type (2020-2025)
2.4 Sevoflurane (Sevoflurane Source) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Sevoflurane (Sevoflurane Source) Sales by Application
2.5.1 Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2020-2025)
2.5.2 Global Sevoflurane (Sevoflurane Source) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Sevoflurane (Sevoflurane Source) Breakdown Data by Company
3.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Company (2020-2025)
3.1.2 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company (2020-2025)
3.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Company (2020-2025)
3.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Company (2020-2025)
3.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company (2020-2025)
3.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Company
3.4 Key Manufacturers Sevoflurane (Sevoflurane Source) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sevoflurane (Sevoflurane Source) Product Location Distribution
3.4.2 Players Sevoflurane (Sevoflurane Source) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEVOFLURANE (SEVOFLURANE SOURCE) BY GEOGRAPHIC REGION
4.1 World Historic Sevoflurane (Sevoflurane Source) Market Size by Geographic Region (2020-2025)
4.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sevoflurane (Sevoflurane Source) Market Size by Country/Region (2020-2025)
4.2.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sevoflurane (Sevoflurane Source) Sales Growth
4.4 APAC Sevoflurane (Sevoflurane Source) Sales Growth
4.5 Europe Sevoflurane (Sevoflurane Source) Sales Growth
4.6 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Growth
5 AMERICAS
5.1 Americas Sevoflurane (Sevoflurane Source) Sales by Country
5.1.1 Americas Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
5.1.2 Americas Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
5.2 Americas Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
5.3 Americas Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sevoflurane (Sevoflurane Source) Sales by Region
6.1.1 APAC Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025)
6.1.2 APAC Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025)
6.2 APAC Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
6.3 APAC Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sevoflurane (Sevoflurane Source) by Country
7.1.1 Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
7.1.2 Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
7.2 Europe Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
7.3 Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sevoflurane (Sevoflurane Source) by Country
8.1.1 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
8.2 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
8.3 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sevoflurane (Sevoflurane Source)
10.3 Manufacturing Process Analysis of Sevoflurane (Sevoflurane Source)
10.4 Industry Chain Structure of Sevoflurane (Sevoflurane Source)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sevoflurane (Sevoflurane Source) Distributors
11.3 Sevoflurane (Sevoflurane Source) Customer
12 WORLD FORECAST REVIEW FOR SEVOFLURANE (SEVOFLURANE SOURCE) BY GEOGRAPHIC REGION
12.1 Global Sevoflurane (Sevoflurane Source) Market Size Forecast by Region
12.1.1 Global Sevoflurane (Sevoflurane Source) Forecast by Region (2026-2031)
12.1.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sevoflurane (Sevoflurane Source) Forecast by Type (2026-2031)
12.7 Global Sevoflurane (Sevoflurane Source) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.1.3 Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.2.3 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.3.3 Maruishi Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.4.3 AbbVie Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.5.3 Piramal Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.6.3 Viatris Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 PT Novell Pharmaceutical
13.7.1 PT Novell Pharmaceutical Company Information
13.7.2 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.7.3 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PT Novell Pharmaceutical Main Business Overview
13.7.5 PT Novell Pharmaceutical Latest Developments
13.8 Lunan Pharma
13.8.1 Lunan Pharma Company Information
13.8.2 Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.8.3 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lunan Pharma Main Business Overview
13.8.5 Lunan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Sevoflurane (Sevoflurane Source) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Sevoflurane (Sevoflurane Source) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 6. Global Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Table 7. Global Sevoflurane (Sevoflurane Source) Revenue byType (2020-2025) & ($ million)
Table 8. Global Sevoflurane (Sevoflurane Source) Revenue Market Share byType (2020-2025)
Table 9. Global Sevoflurane (Sevoflurane Source) Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Sevoflurane (Sevoflurane Source) Sale by Application (2020-2025) & (K Units)
Table 11. Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2020-2025)
Table 12. Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2025)
Table 14. Global Sevoflurane (Sevoflurane Source) Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Sevoflurane (Sevoflurane Source) Sales by Company (2020-2025) & (K Units)
Table 16. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company (2020-2025)
Table 17. Global Sevoflurane (Sevoflurane Source) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company (2020-2025)
Table 19. Global Sevoflurane (Sevoflurane Source) Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Sevoflurane (Sevoflurane Source) Producing Area Distribution and Sales Area
Table 21. Players Sevoflurane (Sevoflurane Source) Products Offered
Table 22. Sevoflurane (Sevoflurane Source) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sevoflurane (Sevoflurane Source) Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Sevoflurane (Sevoflurane Source) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Sevoflurane (Sevoflurane Source) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Sevoflurane (Sevoflurane Source) Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Sevoflurane (Sevoflurane Source) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 34. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2025)
Table 35. Americas Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 37. Americas Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 38. APAC Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 39. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2025)
Table 40. APAC Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 42. APAC Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 43. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 44. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 46. Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sevoflurane (Sevoflurane Source)
Table 52. Key Market Challenges & Risks of Sevoflurane (Sevoflurane Source)
Table 53. Key IndustryTrends of Sevoflurane (Sevoflurane Source)
Table 54. Sevoflurane (Sevoflurane Source) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sevoflurane (Sevoflurane Source) Distributors List
Table 57. Sevoflurane (Sevoflurane Source) Customer List
Table 58. Global Sevoflurane (Sevoflurane Source) SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Sevoflurane (Sevoflurane Source) RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Sevoflurane (Sevoflurane Source) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Sevoflurane (Sevoflurane Source) SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Sevoflurane (Sevoflurane Source) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Sevoflurane (Sevoflurane Source) RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Sevoflurane (Sevoflurane Source) RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Sevoflurane (Sevoflurane Source) SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Sevoflurane (Sevoflurane Source) RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Sevoflurane (Sevoflurane Source) SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Sevoflurane (Sevoflurane Source) RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Hengrui Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 74. Hengrui Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Hengrui Main Business
Table 76. Hengrui Latest Developments
Table 77. Baxter Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 79. Baxter Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Maruishi Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 83. Maruishi Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 84. Maruishi Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Maruishi Main Business
Table 86. Maruishi Latest Developments
Table 87. AbbVie Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 89. AbbVie Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 94. Piramal Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. Viatris Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 99. Viatris Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. PT Novell Pharmaceutical Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 103. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 104. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. PT Novell Pharmaceutical Main Business
Table 106. PT Novell Pharmaceutical Latest Developments
Table 107. Lunan Pharma Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 108. Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 109. Lunan Pharma Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Lunan Pharma Main Business
Table 111. Lunan Pharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Sevoflurane (Sevoflurane Source)
Figure 2. Sevoflurane (Sevoflurane Source) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sevoflurane (Sevoflurane Source) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Sevoflurane (Sevoflurane Source) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Sevoflurane (Sevoflurane Source) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2024)
Figure 10. Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Original Drugs
Figure 12. Product Picture of Generic Drugs
Figure 13. Global Sevoflurane (Sevoflurane Source) Sales Market Share byType in 2025
Figure 14. Global Sevoflurane (Sevoflurane Source) Revenue Market Share byType (2020-2025)
Figure 15. Sevoflurane (Sevoflurane Source) Consumed in Hospital
Figure 16. Global Sevoflurane (Sevoflurane Source) Market: Hospital (2020-2025) & (K Units)
Figure 17. Sevoflurane (Sevoflurane Source) Consumed in Clinics
Figure 18. Global Sevoflurane (Sevoflurane Source) Market: Clinics (2020-2025) & (K Units)
Figure 19. Sevoflurane (Sevoflurane Source) Consumed in Other
Figure 20. Global Sevoflurane (Sevoflurane Source) Market: Other (2020-2025) & (K Units)
Figure 21. Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2024)
Figure 22. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application in 2025
Figure 23. Sevoflurane (Sevoflurane Source) Sales by Company in 2025 (K Units)
Figure 24. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company in 2025
Figure 25. Sevoflurane (Sevoflurane Source) Revenue by Company in 2025 ($ millions)
Figure 26. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company in 2025
Figure 27. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 30. Americas Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 31. APAC Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 32. APAC Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 33. Europe Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 34. Europe Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 37. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Country in 2025
Figure 38. Americas Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Figure 39. Americas Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 40. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 41. United States Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Region in 2025
Figure 46. APAC Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2025)
Figure 47. APAC Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 48. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 49. China Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 53. India Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Country in 2025
Figure 57. Europe Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Figure 58. Europe Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 59. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 60. Germany Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 61.France Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 68. Egypt Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sevoflurane (Sevoflurane Source) in 2025
Figure 74. Manufacturing Process Analysis of Sevoflurane (Sevoflurane Source)
Figure 75. Industry Chain Structure of Sevoflurane (Sevoflurane Source)
Figure 76. Channels of Distribution
Figure 77. Global Sevoflurane (Sevoflurane Source) Sales MarketForecast by Region (2026-2031)
Figure 78. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Sevoflurane (Sevoflurane Source) Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Sevoflurane (Sevoflurane Source) Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sevoflurane (Sevoflurane Source) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sevoflurane (Sevoflurane Source) by Country/Region, 2020, 2024 & 2031
2.2 Sevoflurane (Sevoflurane Source) Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Sevoflurane (Sevoflurane Source) Sales by Type
2.3.1 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Type (2020-2025)
2.3.2 Global Sevoflurane (Sevoflurane Source) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Type (2020-2025)
2.4 Sevoflurane (Sevoflurane Source) Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Sevoflurane (Sevoflurane Source) Sales by Application
2.5.1 Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2020-2025)
2.5.2 Global Sevoflurane (Sevoflurane Source) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Sevoflurane (Sevoflurane Source) Breakdown Data by Company
3.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Company (2020-2025)
3.1.2 Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company (2020-2025)
3.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Company (2020-2025)
3.2.1 Global Sevoflurane (Sevoflurane Source) Revenue by Company (2020-2025)
3.2.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company (2020-2025)
3.3 Global Sevoflurane (Sevoflurane Source) Sale Price by Company
3.4 Key Manufacturers Sevoflurane (Sevoflurane Source) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sevoflurane (Sevoflurane Source) Product Location Distribution
3.4.2 Players Sevoflurane (Sevoflurane Source) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEVOFLURANE (SEVOFLURANE SOURCE) BY GEOGRAPHIC REGION
4.1 World Historic Sevoflurane (Sevoflurane Source) Market Size by Geographic Region (2020-2025)
4.1.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sevoflurane (Sevoflurane Source) Market Size by Country/Region (2020-2025)
4.2.1 Global Sevoflurane (Sevoflurane Source) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sevoflurane (Sevoflurane Source) Sales Growth
4.4 APAC Sevoflurane (Sevoflurane Source) Sales Growth
4.5 Europe Sevoflurane (Sevoflurane Source) Sales Growth
4.6 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Growth
5 AMERICAS
5.1 Americas Sevoflurane (Sevoflurane Source) Sales by Country
5.1.1 Americas Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
5.1.2 Americas Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
5.2 Americas Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
5.3 Americas Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sevoflurane (Sevoflurane Source) Sales by Region
6.1.1 APAC Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025)
6.1.2 APAC Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025)
6.2 APAC Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
6.3 APAC Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sevoflurane (Sevoflurane Source) by Country
7.1.1 Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
7.1.2 Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
7.2 Europe Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
7.3 Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sevoflurane (Sevoflurane Source) by Country
8.1.1 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025)
8.2 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Type (2020-2025)
8.3 Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sevoflurane (Sevoflurane Source)
10.3 Manufacturing Process Analysis of Sevoflurane (Sevoflurane Source)
10.4 Industry Chain Structure of Sevoflurane (Sevoflurane Source)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sevoflurane (Sevoflurane Source) Distributors
11.3 Sevoflurane (Sevoflurane Source) Customer
12 WORLD FORECAST REVIEW FOR SEVOFLURANE (SEVOFLURANE SOURCE) BY GEOGRAPHIC REGION
12.1 Global Sevoflurane (Sevoflurane Source) Market Size Forecast by Region
12.1.1 Global Sevoflurane (Sevoflurane Source) Forecast by Region (2026-2031)
12.1.2 Global Sevoflurane (Sevoflurane Source) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sevoflurane (Sevoflurane Source) Forecast by Type (2026-2031)
12.7 Global Sevoflurane (Sevoflurane Source) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.1.3 Hengrui Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.2.3 Baxter Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.3.3 Maruishi Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.4.3 AbbVie Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.5.3 Piramal Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.6.3 Viatris Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 PT Novell Pharmaceutical
13.7.1 PT Novell Pharmaceutical Company Information
13.7.2 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.7.3 PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PT Novell Pharmaceutical Main Business Overview
13.7.5 PT Novell Pharmaceutical Latest Developments
13.8 Lunan Pharma
13.8.1 Lunan Pharma Company Information
13.8.2 Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
13.8.3 Lunan Pharma Sevoflurane (Sevoflurane Source) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lunan Pharma Main Business Overview
13.8.5 Lunan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Sevoflurane (Sevoflurane Source) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Sevoflurane (Sevoflurane Source) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 6. Global Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Table 7. Global Sevoflurane (Sevoflurane Source) Revenue byType (2020-2025) & ($ million)
Table 8. Global Sevoflurane (Sevoflurane Source) Revenue Market Share byType (2020-2025)
Table 9. Global Sevoflurane (Sevoflurane Source) Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Sevoflurane (Sevoflurane Source) Sale by Application (2020-2025) & (K Units)
Table 11. Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2020-2025)
Table 12. Global Sevoflurane (Sevoflurane Source) Revenue by Application (2020-2025) & ($ million)
Table 13. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2020-2025)
Table 14. Global Sevoflurane (Sevoflurane Source) Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Sevoflurane (Sevoflurane Source) Sales by Company (2020-2025) & (K Units)
Table 16. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company (2020-2025)
Table 17. Global Sevoflurane (Sevoflurane Source) Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company (2020-2025)
Table 19. Global Sevoflurane (Sevoflurane Source) Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Sevoflurane (Sevoflurane Source) Producing Area Distribution and Sales Area
Table 21. Players Sevoflurane (Sevoflurane Source) Products Offered
Table 22. Sevoflurane (Sevoflurane Source) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sevoflurane (Sevoflurane Source) Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Sevoflurane (Sevoflurane Source) Sales Market Share Geographic Region (2020-2025)
Table 27. Global Sevoflurane (Sevoflurane Source) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Sevoflurane (Sevoflurane Source) Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2020-2025)
Table 31. Global Sevoflurane (Sevoflurane Source) Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 34. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2025)
Table 35. Americas Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 37. Americas Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 38. APAC Sevoflurane (Sevoflurane Source) Sales by Region (2020-2025) & (K Units)
Table 39. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Region (2020-2025)
Table 40. APAC Sevoflurane (Sevoflurane Source) Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 42. APAC Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 43. Europe Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 44. Europe Sevoflurane (Sevoflurane Source) Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 46. Europe Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sevoflurane (Sevoflurane Source)
Table 52. Key Market Challenges & Risks of Sevoflurane (Sevoflurane Source)
Table 53. Key IndustryTrends of Sevoflurane (Sevoflurane Source)
Table 54. Sevoflurane (Sevoflurane Source) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sevoflurane (Sevoflurane Source) Distributors List
Table 57. Sevoflurane (Sevoflurane Source) Customer List
Table 58. Global Sevoflurane (Sevoflurane Source) SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Sevoflurane (Sevoflurane Source) RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Sevoflurane (Sevoflurane Source) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Sevoflurane (Sevoflurane Source) SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Sevoflurane (Sevoflurane Source) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Sevoflurane (Sevoflurane Source) RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Sevoflurane (Sevoflurane Source) SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Sevoflurane (Sevoflurane Source) RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Sevoflurane (Sevoflurane Source) SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Sevoflurane (Sevoflurane Source) RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Sevoflurane (Sevoflurane Source) SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Sevoflurane (Sevoflurane Source) RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Hengrui Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 74. Hengrui Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Hengrui Main Business
Table 76. Hengrui Latest Developments
Table 77. Baxter Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 79. Baxter Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Maruishi Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 83. Maruishi Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 84. Maruishi Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Maruishi Main Business
Table 86. Maruishi Latest Developments
Table 87. AbbVie Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 89. AbbVie Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 94. Piramal Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. Viatris Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 99. Viatris Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. PT Novell Pharmaceutical Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 103. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 104. PT Novell Pharmaceutical Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. PT Novell Pharmaceutical Main Business
Table 106. PT Novell Pharmaceutical Latest Developments
Table 107. Lunan Pharma Basic Information, Sevoflurane (Sevoflurane Source) Manufacturing Base, Sales Area and Its Competitors
Table 108. Lunan Pharma Sevoflurane (Sevoflurane Source) Product Portfolios and Specifications
Table 109. Lunan Pharma Sevoflurane (Sevoflurane Source) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Lunan Pharma Main Business
Table 111. Lunan Pharma Latest Developments
LIST OFFIGURES
Figure 1. Picture of Sevoflurane (Sevoflurane Source)
Figure 2. Sevoflurane (Sevoflurane Source) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sevoflurane (Sevoflurane Source) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Sevoflurane (Sevoflurane Source) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Sevoflurane (Sevoflurane Source) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2024)
Figure 10. Sevoflurane (Sevoflurane Source) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Original Drugs
Figure 12. Product Picture of Generic Drugs
Figure 13. Global Sevoflurane (Sevoflurane Source) Sales Market Share byType in 2025
Figure 14. Global Sevoflurane (Sevoflurane Source) Revenue Market Share byType (2020-2025)
Figure 15. Sevoflurane (Sevoflurane Source) Consumed in Hospital
Figure 16. Global Sevoflurane (Sevoflurane Source) Market: Hospital (2020-2025) & (K Units)
Figure 17. Sevoflurane (Sevoflurane Source) Consumed in Clinics
Figure 18. Global Sevoflurane (Sevoflurane Source) Market: Clinics (2020-2025) & (K Units)
Figure 19. Sevoflurane (Sevoflurane Source) Consumed in Other
Figure 20. Global Sevoflurane (Sevoflurane Source) Market: Other (2020-2025) & (K Units)
Figure 21. Global Sevoflurane (Sevoflurane Source) Sale Market Share by Application (2024)
Figure 22. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application in 2025
Figure 23. Sevoflurane (Sevoflurane Source) Sales by Company in 2025 (K Units)
Figure 24. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Company in 2025
Figure 25. Sevoflurane (Sevoflurane Source) Revenue by Company in 2025 ($ millions)
Figure 26. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company in 2025
Figure 27. Global Sevoflurane (Sevoflurane Source) Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 30. Americas Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 31. APAC Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 32. APAC Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 33. Europe Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 34. Europe Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Sevoflurane (Sevoflurane Source) Revenue 2020-2025 ($ millions)
Figure 37. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Country in 2025
Figure 38. Americas Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Figure 39. Americas Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 40. Americas Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 41. United States Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Region in 2025
Figure 46. APAC Sevoflurane (Sevoflurane Source) Revenue Market Share by Region (2020-2025)
Figure 47. APAC Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 48. APAC Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 49. China Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 53. India Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Country in 2025
Figure 57. Europe Sevoflurane (Sevoflurane Source) Revenue Market Share by Country (2020-2025)
Figure 58. Europe Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 59. Europe Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 60. Germany Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 61.France Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Sevoflurane (Sevoflurane Source) Sales Market Share by Application (2020-2025)
Figure 68. Egypt Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Sevoflurane (Sevoflurane Source) Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sevoflurane (Sevoflurane Source) in 2025
Figure 74. Manufacturing Process Analysis of Sevoflurane (Sevoflurane Source)
Figure 75. Industry Chain Structure of Sevoflurane (Sevoflurane Source)
Figure 76. Channels of Distribution
Figure 77. Global Sevoflurane (Sevoflurane Source) Sales MarketForecast by Region (2026-2031)
Figure 78. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Sevoflurane (Sevoflurane Source) Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Sevoflurane (Sevoflurane Source) Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Sevoflurane (Sevoflurane Source) Revenue Market ShareForecast by Application (2026-2031)
